Incidence and Risk Factors of Illnesses Presumably Caused by A SARS-CoV-2 Infection in The General Population During The Lockdown Period: A Multi-Cohort Study.

Background Our main objectives were to estimate the incidence of illnesses presumably caused by SARS-CoV-2 infection during the lockdown period and to identify the associated risk factors.Methods Participants from 3 adult cohorts in the general population in France were invited to participate in a survey on COVID-19. The main outcome was possible COVID-19, defined as a sudden onset of cough, fever, dyspnea, ageusia and/or anosmia, that lasted more than 3 days and occurred during the 17 days before the survey. We used delayed-entry Cox models to identify associated factors.Results Between April 2, 2020 and May 12, 2020, 279,478 participants were invited, 116,903 validated the questionnaire and 106,848 were included in the analysis. Three thousand thirty-five cases of possible COVID-19 were reported during 62,099 person-months of follow-up. The cumulative incidences of possible COVID-19 were 6.2% (95% Confidence Interval (95%CI): 5.7%; 6.6%) on day 15 and 8.8% (95%CI 8.3%; 9.2%) on day 45 of lockdown. The risk of possible COVID-19 was lower in older age groups and higher in French regions with a high prevalence of SARS-CoV-2 infection, in participants living in cities >100,000 inhabitants (vs rural areas), when at least one child or adolescent was living in the same household, in overweight or obese people, and in people with chronic respiratory diseases, anxiety or depression or chronic diseases other than diabetes, cancer, hypertension or cardiovascular diseases. Conclusion The incidence of possible COVID-19 in the general population remained high during the first two weeks of lockdown, and decreased significantly thereafter. Modifiable and non-modifiable risk factors were identified.

[1]  N. Akilli,et al.  Prevalence of Asymptomatic SARS-CoV-2 Infection , 2021, Annals of Internal Medicine.

[2]  D. Pigott,et al.  Crowding and the shape of COVID-19 epidemics , 2020, Nature medicine.

[3]  I. Bogoch,et al.  Web and phone-based COVID-19 syndromic surveillance in Canada: A cross-sectional study , 2020, PloS one.

[4]  M. Hernán,et al.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.

[5]  L. Fang,et al.  Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.

[6]  S. Bhatt,et al.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.

[7]  Andrej Belančić,et al.  Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity , 2020, Obesity Medicine.

[8]  Y. Leo,et al.  Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  J. Lessler,et al.  Estimating the burden of SARS-CoV-2 in France , 2020, Science.

[10]  Mingkun Zhan,et al.  Death from Covid-19 of 23 Health Care Workers in China , 2020, The New England journal of medicine.

[11]  Jiaofeng Huang,et al.  The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis , 2020, Journal of medical virology.

[12]  Anne Kimball,et al.  Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility — King County, Washington, March 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[13]  D. Halpin,et al.  Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? , 2020, The Lancet Respiratory Medicine.

[14]  D. Sin,et al.  ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 , 2020, European Respiratory Journal.

[15]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[16]  N. Linton,et al.  Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) , 2020, International Journal of Infectious Diseases.

[17]  M. Zins,et al.  The French CONSTANCES population-based cohort: design, inclusion and follow-up , 2015, European Journal of Epidemiology.

[18]  F. Clavel-Chapelon Cohort Profile: The French E3N Cohort Study. , 2015, International journal of epidemiology.

[19]  M. Touvier,et al.  The Nutrinet-Santé Study: a web-based prospective study on the relationship between nutrition and health and determinants of dietary patterns and nutritional status , 2010 .

[20]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .